bpc 157 clinical trial recruiting 2025 BPC-157: What the Science Actually Says bpc 157 human clinical trial

Patients with one or more of these variant CYP2C9 alleles have decreased S-warfarin clearance (Table 1).2 Other CYP2C9 alleles associated with reduced enzymatic activity occur at lower frequencies, including *5, *6, and *11 alleles in populations of African ancestry and *5, *9 and *11 alleles in Caucasians

Unlike regular LDL cholesterol, Lp(a) also promotes blood clotting and inflammation, making it particularly concerning for heart health

BPC-157 is not approved for human use by any regulatory agency

FDA-cleared procedure to safely target and remove diet and exercise resistant fat

Gandomi H, Abbaszadeh S, Rahimikia E, Shariatifar N